GlassScriptPhysician profile
Theodor M Rudolph
NPI 1700861382
$4,563.02
in general payments reported to CMS, 2019-2025
16 companies · $1,251 in 2025
The $1,251 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $64.00 · 2021: $241 · 2022: $276 · 2023: $490 · 2024: $1,912 · 2025: $1,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,422 · Travel and Lodging: $1,110 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,421.96 |
| Travel and Lodging | $1,110.24 |
| Education | $120.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,796.49 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Janssen Biotech, INC. | $1,182.00 | 2020-2025 | Tremfya |
| Merz North America, INC. | $626.22 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $236.46 | 2023-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $211.47 | 2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $94.94 | 2019-2025 | |
| Genzyme Corporation | $79.23 | 2024 | |
| Pfizer INC. | $60.37 | 2019-2022 | |
| Allergan, INC. | $54.44 | 2019-2021 | |
| Lilly USA, LLC | $50.79 | 2024 | Taltz, Olumiant |
| Abbvie INC. | $45.22 | 2021-2023 | |
| Ucb, INC. | $34.97 | 2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.12 | 2025 | Spevigo |
| Amgen INC. | $25.00 | 2020 | |
| Incyte Corporation | $23.30 | 2023 | Opzelura |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $14.00 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodor Rudolph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.